Advanced imaging for stratifying treatment in oligometastatic prostate cancer - ESR Connect

JOINT SESSION of the ESR and EORTC

ESR/EORTC - Advanced imaging for stratifying treatment in oligometastatic prostate cancer

  • 2 Lectures
  • 48 Minutes
  • 2 Speakers
No access granted. Register to watch.

Lectures

1
ESR/EORTC_1 - Whole-body MRI: is it ready for prime time to detect oligometastatic prostate cancer?

ESR/EORTC_1 - Whole-body MRI: is it ready for prime time to detect oligometastatic prostate cancer?

28:00Frederik de Keyzer, Leuven / BE

Learning Objectives
1. To learn about whole-body MRI: how to optimise the technique.
2. To appreciate the technical challenges and limitations of the technique in prostate cancer patients.
3. To understand how the output may be quantified and assessed.

2
ESR/EORTC_2 - Molecular imaging for directing and delivering therapy in oligometastatic prostate cancer

ESR/EORTC_2 - Molecular imaging for directing and delivering therapy in oligometastatic prostate cancer

20:22Daniela Oprea-Lager, Amsterdam / NL

Learning Objectives
1. To learn about targeted imaging and radionuclide therapy in oligometastatic prostate cancer.
2. To appreciate how molecular imaging may be used to stratify therapy.
3. To understand how to devise trials that establish an evidence-based use of modern imaging techniques.